Opendata, web and dolomites

PROSCOPE SIGNED

Point-of-care instrument for diagnosis and image-guided intervention of Colo-Rectal Cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PROSCOPE project word cloud

Explore the words cloud of the PROSCOPE project. It provides you a very rough idea of what is the project "PROSCOPE" about.

biopsies    white    incurred    save    validated    optical    entire    clinics    develops    hospital    band    benefitting    rate    video    reducing    treatment    colonoscopy    clinical    settings    huge    time    colon    specificity    caught    90    techniques    survival    detection    manufacturer    dramatically    proven    offers    planning    rates    50    recurrence    medical    sensitive    morphological    endoscopes    invasive    vivo    point    healthcare    validation    device    academics    business    onset    cancer    narrow    types    proscope    screening    pathology    combination    cancerous    modalities    label    polyp    thereby    minimally    complete    single    inadequate    light    excisional    biochemical    gastroenterological    colorectal    provides    guided    sensitivity    unmet    vastly    image    characterisation    clinicians    imaging    diagnosis    fits    drastically    patients    smes    integrates    free    chain    found    crc    interval    platform    lesions    care    death    stage    clear    probe    intervention    unfortunately    ionizing   

Project "PROSCOPE" data sheet

The following table provides information about the project.

Coordinator
DANMARKS TEKNISKE UNIVERSITET 

Organization address
address: ANKER ENGELUNDSVEJ 1 BYGNING 101 A
city: KGS LYNGBY
postcode: 2800
website: www.dtu.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 5˙999˙383 €
 EC max contribution 5˙999˙383 € (100%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
 Code Call H2020-ICT-2019-2
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) coordinator 1˙081˙250.00
2    MEDIZINISCHE UNIVERSITAET WIEN AT (WIEN) participant 953˙750.00
3    THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS UK (ST ANDREWS) participant 818˙143.00
4    ALBERT-LUDWIGS-UNIVERSITAET FREIBURG DE (FREIBURG) participant 685˙250.00
5    M-SQUARED LASERS LIMITED UK (GLASGOW) participant 651˙750.00
6    OVESCO ENDOSCOPY AG DE (TUBINGEN) participant 607˙631.00
7    GRINTECH GMBH DE (Jena) participant 539˙483.00
8    UNIVERSITAETSKLINIKUM FREIBURG DE (FREIBURG) participant 311˙375.00
9    Q4 PR LIMITED IE (DUBLIN 2) participant 231˙875.00
10    DIN DEUTSCHES INSTITUT FUER NORMUNG E.V. DE (BERLIN) participant 118˙875.00

Map

 Project objective

Colorectal cancer (CRC) is the second most common cause of cancer death in Europe, yet survival rates rise dramatically when caught early. A contributing factor is that current colonoscopy, i.e., white light video or optical narrow band imaging, is inadequate for in-vivo detection and characterisation of the various types of (pre-)cancerous lesions found in the colon. Point-of-care, real-time polyp diagnosis and image guided intervention has the potential to save huge healthcare costs by enabling early onset of treatment; thus reduced recurrence rate, by improving interval screening, and by reducing pathology costs incurred during colonoscopy. A complete, reliable optical diagnosis is sensitive to morphological and biochemical changes. Unfortunately, no single optical method provides both. PROSCOPE provides unique combination of label-free, non-ionizing, proven optical imaging modalities that provides higher sensitivity and specificity compared to current colonoscopy thus enabling a step-change in point-of-care management of CRC. PROSCOPE develops and integrates recent advances in optical imaging and optical probe technology into one platform. The concept is validated in clinical settings using existing endoscopes providing minimally invasive optical imaging that fits into current clinical procedures. A leading medical device manufacturer and clinicians are involved at every stage of the development and validation. PROSCOPE is driven by unmet clinical needs in the field of gastroenterological diagnosis with a clear business case: Combination of optical imaging techniques offers the potential to vastly improve early diagnosis of CRC achieving specificity and sensitivity above 90%, reducing the number of excisional biopsies by 50%, and improving interval screening planning, thereby reducing healthcare costs drastically and benefitting patients. The consortium includes five leading academics, including hospital clinics, and four SMEs covering the entire value chain.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROSCOPE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROSCOPE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.)

EVOLVE (2018)

HPC and Cloud-enhanced Testbed for Extracting Value from Diverse Data at Large Scale

Read More  

5G ALL-STAR (2018)

5G AgiLe and fLexible integration of SaTellite And cellulaR

Read More  

5G-DIVE (2019)

5G-DIVE: eDge Intelligence for Vertical Experimentation

Read More